FIELD: medicine.
SUBSTANCE: invention relates to method of treating patient with Gaucher's disease, which involves administering to patient requiring treatment, effective amount of at least one compound selected from group consisting of:
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
.
Invention also relates to version of method of treating patient with Gaucher's disease and to kit with activity on glucocerebrosidase, comprising container with effective amount of at least one compound of invention.
EFFECT: technical result: method of treating patient with Gaucher's disease with new derivatives of piperidine-3,4-diol is disclosed.
11 cl, 10 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITIONS FOR PREVENTING OR TREATING DEGENERATIVE DISEASES OF CENTRAL NERVOUS SYSTEM | 2010 |
|
RU2581058C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| COMPOUNDS - SULFAMATE DERIVATIVES FOR USE IN TREATING OR RELIEVING PAIN | 2014 |
|
RU2699025C1 |
| METHOD FOR PRODUCING (2R,3R,4R,5S)-1-BUTYL-2-(HYDROXYMETHYL)PIPERIDINE-3,4,5-TRIOL | 2020 |
|
RU2762605C1 |
| DERIVATIVES OF PIPERIDINE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2279425C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2592285C2 |
| METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
| GLYCOSIDASE INHIBITORS AND THEIR APPLICATIONS | 2013 |
|
RU2672873C2 |
